INDUSTRY PERSPECTIVE
State of Private Hospitals sector in Australia
Michael Roff CEO Australian Private Hospitals Association
The Australian Private Hospitals Association is the leading industry body that represents the majority of private hospitals in Australia. They provide a diverse range of healthcare services, including general medical surgical hospitals, mental health facilities, and hospitals that provide inpatient rehabilitation. Private hospitals play a crucial role in the Australian health system, comprising about 30% of all hospital beds and provide 40% of admissions and 60% of all surgeries.
The Chief Executive Officer of the Australian Private Hospitals Association (APHA), Michael Roff, has served APHA for the past 30 years, first as Public Affairs Manager in 1994 before being appointed CEO in March 2000.
Recently Mr Roff, advised the APHA Board he will be stepping down in July 2024. Australian Health Journal spoke with him to discuss the recent announcement by the Federal Government to retain the General Use Items, an issue APHA has successfully lobbied to retain over the past few years.
Mr Roff also discusses his broader thoughts on the current state of the private hospital sector in Australia and reflecting on the changes over the past 30 years whilst working at APHA and 24 years as the Chief Executive Officer.
Mr Roff talks about the financial challenges due to long-term underfunding, which has led to many hospitals struggling to meet their usual capital expenditure. This issue has caused some private hospitals to close, which reduces the healthcare options available to Australians. According to Mr Roff, it is essential to address this issue to ensure that Australians continue to have access to high-quality, private healthcare services.
The growth in exclusionary health insurance products is also a problem that needs attention, says Mr Roff. Many Australians cannot adequately self-assess their own risk of needing a particular hospital service, which makes it difficult for them to choose the right health insurance policy. Additionally, health insurance intermediaries, which compare health insurance products and provide recommendations, often work on a commission basis, which may not necessarily provide consumers with the best options available.
“To address these issues, it is necessary to create a balanced system that benefits both private hospitals and private health insurance companies. Private hospitals need to receive adequate funding to continue to provide high-quality healthcare services, and private health insurance companies should provide fair payments to private hospitals for their services.”, says Mr Roff.
During Mr Roff’s working career at APHA he has represented the private hospitals sector to nine different Federal Health Ministers and eight Prime Ministers. He believes the government should take steps to regulate the health insurance industry to protect consumers and ensure that Australians have access to affordable and comprehensive healthcare services.
“I have spent half my life and the majority of my professional life with APHA and it has been an honour to represent a sector committed to providing the highest quality health services to millions of Australians each year”, Mr Roff said.
You Might also like
-
Elevating Professional Standards in the Medtech and Pharmaceutical Sector
ARCS Australia Ltd, the peak body representing professionals in the MedTech and Pharmaceutical sector, this week announced a series of significant changes at its annual conference.
Dr Tim Boyle, CEO of ARCS Australia Ltd speaking to Australian Health Journal says, “These initiatives are central to strategy to build professionalism within the sector, increase capability and enhance the professional standing of its members.”
-
Value of MedTech Report brings Industry and Government together
In June 2023 the Medical Technology Association of Australia (MTAA) launched The Value of MedTech Report – a major study quantifying the difference the MedTech industry makes to the lives of Australian patients, the healthcare system and the Australian economy.
Australian Health Journal spoke with MTAA CEO, Ian Burgess and MTAA Policy Manager, Pravin Siriwardena about the report and its key findings.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy.
Australian Health Journal met with 3 speakers at the recent ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.